Glucotrack (GCTK) Shares Outstanding (Diluted Average) (2012 - 2025)
Glucotrack (GCTK) recorded quarterly Shares Outstanding (Diluted Average) of $621094.0 in Q4 2025, up 18.57% on a QoQ basis from $523833.0 in Q3 2025, and up 11186.46% year-over-year from N/an in Q4 2024.
Glucotrack (GCTK) Shares Outstanding (Diluted Average) (2012 - 2025) Analysis & Trends
Glucotrack has disclosed Shares Outstanding (Diluted Average) across 12 years of filings, most recently posting $621094.0 for Q4 2025.
- Quarterly Shares Outstanding (Diluted Average) rose 11186.46% year-over-year to $621094.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $621094.0 (up 11186.46% YoY) and the FY2025 annual result came in at $621094.0, up 11186.46% from the prior year.
- Shares Outstanding (Diluted Average) climbed to $621094.0 in Q4 2025, from $523833.0 in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $15.5 million in Q1 2023 and troughed at $4363.0 in Q2 2024.
- A 4-year average of $5.5 million and a median of $621094.0 in 2025 frame the typical range for Shares Outstanding (Diluted Average).
- Annual changes were most pronounced in 2024 — Shares Outstanding (Diluted Average) tumbled 99.88% — and 2025, when it jumped 11234.04%.
- Tracing GCTK's Shares Outstanding (Diluted Average) over 4 years: stood at $15.5 million in 2022, then slumped by 98.66% to $207603.0 in 2023, then tumbled by 97.35% to $5503.0 in 2024, then jumped by 11186.46% to $621094.0 in 2025.
- Business Quant data shows GCTK's Shares Outstanding (Diluted Average) at $621094.0 in Q4 2025, $523833.0 in Q3 2025, and $494504.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 824.84 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.72 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 175.50 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.61 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Glucotrack | 4.26 | -7.38 Mn | - | 621,094.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 621,094.00 |
| Sep 30, 2025 | 523,833.00 |
| Jun 30, 2025 | 494,504.00 |
| Mar 31, 2025 | 10.16 Mn |
| Dec 31, 2024 | 5,503.00 |
| Sep 30, 2024 | 4,663.00 |
| Jun 30, 2024 | 4,363.00 |
| Mar 31, 2024 | 249,598.00 |
| Dec 31, 2023 | 207,603.00 |
| Sep 30, 2023 | 4.01 Mn |
| Jun 30, 2023 | 3.71 Mn |
| Mar 31, 2023 | 15.50 Mn |
| Dec 31, 2022 | 15.47 Mn |
| Sep 30, 2022 | 15.47 Mn |
| Jun 30, 2022 | 15.47 Mn |
| Sep 30, 2019 | 152.24 Mn |
| Jun 30, 2019 | 147.26 Mn |
| Dec 31, 2018 | 8.40 Mn |
| Sep 30, 2018 | 8.25 Mn |
| Jun 30, 2018 | 7.56 Mn |